Date published Title
23 Oct 2020 Gold Looks For Footing After Pause Button Hit on U.S. Stimulus
23 Oct 2020 Dow Slips on Intel-Led Tech Selling, No Stimulus Yet
23 Oct 2020 Dollar Heads for Weekly Loss, as Experts Warn Near-Term Reprieve Unlikely
23 Oct 2020 Germany stocks mixed at close of trade; DAX up 0.82%
23 Oct 2020 France stocks higher at close of trade; CAC 40 up 1.20%
23 Oct 2020 Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.21%
23 Oct 2020 Crude Oil Prices Slip as Libyan Peace Deal Cements Supply Increase
23 Oct 2020 It's All Fun and Games for Mattel After Barbie-Driven Beat
23 Oct 2020 Wall Street Drifts Higher at Open as Election Looms Large; Dow up 60 Pts
23 Oct 2020 Gilead, Barclays Rise Premarket; Intel Slumps
23 Oct 2020 U.S. Futures Just Higher; Stimulus, Gilead Drug in Focus
23 Oct 2020 India stocks higher at close of trade; Nifty 50 up 0.28%
23 Oct 2020 StockBeat: Hotel Heartbreak Eases - a Little - in Q3
23 Oct 2020 European Stocks Gain on Signs of Economic Recovery; Carmakers Shine
23 Oct 2020 Japan stocks higher at close of trade; Nikkei 225 up 0.18%
23 Oct 2020 Dollar Edges Higher After Presidential Debate
23 Oct 2020 Australia stocks lower at close of trade; S&P/ASX 200 down 0.11%
23 Oct 2020 European Stocks Mixed; Investors Digest U.S. Presidential Debate
23 Oct 2020 Dollar Up, Ending Tough Week, Investors Digest Trump-Biden Debate
23 Oct 2020 Gold Up Over Strengthening Dollar, Trump and Biden Debate
23 Oct 2020 Oil Up After Russia Indicates Openness to Extending Production Cuts
23 Oct 2020 Asian Stocks Up, After “Slightly More Civilized” Trump-Biden Debate
22 Oct 2020 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.54%
22 Oct 2020 Gilead's Covid-19 Drug Wins Full FDA Approval
22 Oct 2020 Dow Bags Gain on Value Stocks; FDA Approves Gilead's Anti-Viral Drug
22 Oct 2020 Gold Snaps Three-Day Rally as Dollar Rebounds, US Stimulus Talks Drag
22 Oct 2020 Debate Fallout, AmEx, ACB: 3 Things to Watch
22 Oct 2020 Dow Gets Pelosi Boost on Signs Stimulus Deal Near
22 Oct 2020 Pound Slips as Experts Say Accidental No-Deal Brexit Remains High
22 Oct 2020 Chipotle Slips as Results Leave Investors Wanting

Pages

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Back to top

Office network

One Financial Markets is the trading name of Axi Financial Services (UK) Ltd, a company registered in England with company number 6050593. Axi Financial Services (UK) Ltd is authorised and regulated by the Financial Conduct Authority in the UK (under firm reference number 466201)

The information on this site is not directed at residents of the United States, Belgium, Poland or any particular country outside the UK and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

www.onefinancialmarkets.com is owned and operated by Axi Financial Services (UK) Ltd.

Award winning broker
We have been presented with a number of awards that recognise the quality of our service and dedication to our clients :

Best FSA Regulated Broker
Saudi Money Expo

Best Education Product
Saudi Money Expo

Best Broker - Online Trading
IAIR Awards

Best Institutional Broker
Saudi Money Expo

Best FX Services Broker
CN Forex

Top International
FX Broker 2015

Saudi Money Expo

Broker of the Year
Online Trading – Middle East

IAIR Awards

Best Forex
Customer Service 2018

JFEX Awards

We accept the following payment methods: